No abstract available.
Latex* ; Polystyrenes* ; Potassium Channels* ; Potassium* ; Vasospasm, Intracranial*

Psoriasis has been known to have various humoral and cellular immune abnormalities. And adenosine deaminase (ADA) activities are known to be decreased in immune deficiency diseases. The present study was designed to measure the activities of ADA in sera and erythrocytes of psoriasis patients by Giustiss method. There were no significant differences in the erythrocytes ADA activities between normal subjects (9, Gp+4 43 units/10 cells) and psoriasis patients (7, 29+3. 64 units /10 cells). The ADA activities in sera of the psoriasis patients (13. 15+3. 43 units/ L) showed lowered activities than those of normal subjects (20. 44-2, 07 units/L).
Adenosine Deaminase* ; Adenosine* ; Deficiency Diseases ; Erythrocytes* ; Humans ; Psoriasis*

A total of 402 cases of tumors in children under 15 years of age diagnosed at NMC. During a period of 10 years from Jan. 1996 to Dec. 1975 were analysed clinically and the following results were obtained. 1) 402 tumors were divided into 185 malignant, 72 bign and 25 unclassified tumors. 2) The age distribution showed more higher frequency in the age group of 0~5 than each age group of 6~10 or 11~15 but not significantly. 3) The sex ratio between male and female was same in begin but male preponderanc in malignant tumors. Age group did not affect the sex ratio. 4) Among 402 tumors, leukemia was the commonest neoplasm showing 21% with 84 cases, and somatic soft tissue(57 cases), larynx and lung (36 cases), genitourinary system (35 cases) and skin (29 cases) in given order of frequency. 5) Among 192 begin tumors, the tumors of somatic soft tissue was the commonest(49 cases), and larynx and lung(36 cases), skin(28 cases), G-I tract(15 cases) in gven order of frequency. 6) Among 185 malignant tumors, leukemia was the commonest(45.4 %) and CNS(15.1%), GU system(8.1%) and malignant lymphoma(7.5%) in given order of frequency.
Age Distribution ; Child* ; Female ; Humans ; Larynx ; Leukemia ; Lung ; Male ; Sex Ratio ; Skin ; Urogenital System

No abstract available.
Myxoma* ; Perineum*

No abstract available.
Lymphadenitis*

We report a case of laparoendoscopic single-site surgery (LESS) for a symptomatic left seminal vesicular cyst and ipsilateral renal agenesis. A 49-year-old man presented with a 1-year history of severe irritation upon voiding and intractable, recurrent hematospermia. A computed tomography scan showed a 68x41x38 mm sized left seminal vesicular cyst with ipsilateral renal agenesis. LESS was performed successfully to treat the seminal vesicle cyst. The total operative time was 125 minutes, and blood loss was minimal. The patient was discharged from the hospital on the second postoperative day.
Congenital Abnormalities ; Hemospermia ; Humans ; Kidney ; Kidney Diseases ; Laparoscopy ; Middle Aged ; Operative Time ; Seminal Vesicles ; Surgical Procedures, Minimally Invasive

BACKGROUND/AIMS: A drug-eluting stent for unresectable malignant biliary obstruction was developed to increase stent patency by preventing tumor ingrowth. The safety and efficacy of a new generation of metallic stents covered with a paclitaxel-incorporated membrane using a Pluronic® mixture (MSCPM-II) were compared prospectively with those of covered metal stents (CMSs) in patients with malignant biliary obstructions. METHODS: This study was initially designed as a prospective randomized trial but was closed early because of a high incidence of early occlusion. Therefore, the data were analyzed using the intent-to-treat method. A total of 72 patients with unresectable distal malignant biliary obstructions were prospectively enrolled. RESULTS: The two groups did not differ significantly in basic characteristics and mean follow-up period (MSCPM-II 194 days vs CMS 277 days, p=0.063). Stent occlusion occurred in 14 patients (35%) who received MSCPM-II and in seven patients (21.9%) who received CMSs. Stent patency and survival time did not significantly differ between the two groups (p=0.355 and p=0.570). The complications were mild and resolved by conservative management in both groups. CONCLUSIONS: There were no significant differences in stent patency or patient survival in MSCPM-II and CMS patients with malignant biliary obstructions.
Biliary Tract Neoplasms ; Drug-Eluting Stents ; Follow-Up Studies ; Humans ; Incidence ; Membranes* ; Methods ; Paclitaxel* ; Pancreatic Neoplasms ; Prospective Studies* ; Self Expandable Metallic Stents ; Stents*

No abstract available.
Actinomycosis*

BACKGROUND AND OBJECTIVES: Angiogenesis and alteration of apoptosis are hypothesized to be the mechanisms of the growth of tumor. Vascular endothelial growth factor (VEGF) is considered to be the most primary factor prompting the angiogenesis in tumor tissue, which also holds the central position in the course of formation and metastasis of tumor and regulates expression of survivin. The survivin protein is the member of inhibitor of apoptosis protein (IAP) family which inhibits apoptosis. Recently, several authors reported survivin and VEGF expression was found in various cancer tissue and they are suggest to play on the important role in cancer development. The purpose of this study is to evaluate the expression of VEGF and survivin and to investigate their correlation with the clinical stage, nodal involvement, and histologic grade in the squamous cell carcinoma of larynx. SUBJECTS AND METHOD: Immunohistochemical staining for the paraffin sections by using a polyclonal antibody for VEGF and survivin by the standard avidin-biotin-peroxidase technique was performed in 19 cases with the squamouse cell carcinoma of larynx. The relationships between the expression of VEGF and survivin and clinicopathological characteristics were analyzed. RESULTS: Immunohistochemical analysis showed the expression of VEGF in 15 of 19 cases (78.9%) and survivin in 19 of 19 cases (100%). There was no correlation between the expression of VEGF and survivin and the clinical stage, nodal involvement, and histologic grade in the squamous cell carcinoma of larynx (p>0.05). But VEGF results in an increased expression of survivin (p<0.05). CONCLUSION: Further study will be needed to understand the relationships between the VEGF and survivin and squamous cell carcinoma of larynx.
Apoptosis ; Carcinoma, Squamous Cell* ; Humans ; Inhibitor of Apoptosis Proteins ; Laryngeal Neoplasms ; Larynx* ; Neoplasm Metastasis ; Paraffin ; Vascular Endothelial Growth Factor A

BACKGROUND: C-reactive protein (CRP) is an acute phase reactant produced in the liver. To assess the influence of liver dysfunction on the production of CRP, we evaluated CRP response to E. coli bacteremia in patients with or without liver cirrhosis (LC). METHODS: 30 LC patients who developed spontaneous peritonitis with E. coli bacteremia were enrolled in the study. Baseline values of total bilirubin, serum albumin, and prothrombin time were obtained within 2 months prior to infection. Liver dysfunction was categorized according to the Child-Pugh score. 30 patients with E. coli bacteremia who had no underlying liver dysfunction were included as a control group. Matched-control of 30 LC patients without evidence of acute infection was also included. The peak CRP values were compared among the groups. RESULTS: In the patients with E. coli bacteremia, the mean value of peak CRP was 7.3 (+/- 5.0) mg/dL in LC patients, 17.9 (+/- 8.3) mg/dL in patients without liver dysfunction (p<0.001). In the advanced LC patients with Child-Pugh class C, the level of CRP was 5.2 (+/- 3.3) mg/dL in patients with E. coli bacteremia, 0.5 (+/- 0.4) mg/dL in patients without acute infection (P<0.001). Child-Pugh score had correlation with decrease of CRP (linear regression test, P=0.004). CONCLUSION: CRP response during E. coli bacteremia was attenuated but maintained even in patients with advanced liver dysfunction.
Bacteremia* ; Bilirubin ; C-Reactive Protein* ; Escherichia coli* ; Escherichia* ; Humans ; Liver Cirrhosis* ; Liver Diseases* ; Liver* ; Peritonitis ; Prothrombin Time ; Serum Albumin